MediciNova logo
MediciNova MNOV
$ 1.97 5.35%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

MediciNova Financial Ratios 2011-2025 | MNOV

Annual Financial Ratios MediciNova

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-7.7 -8.2 -11.5 -18.6 -19.8 -24.0 -26.2 -16.8 -12.1 -9.9 -12.0 -2.9 -1.5

P/S

65.7 - 28.8 - - - - - - - 8.1 39.6 -

EPS

-0.2 -0.3 -0.2 -0.3 -0.3 -0.4 -0.3 -0.3 -0.3 -0.4 -0.2 -0.7 -1.2

EV (Enterprise Value)

18.6 M 101 M 48.4 M 202 M 196 M 293 M 269 M 164 M 90.2 M 84.6 M 45.9 M 32.4 M 19.6 M

EBITDA per Share

-0.2 -0.3 -0.21 -0.317 -0.325 -0.378 -0.37 -0.329 -0.331 -0.382 -0.189 -0.63 -1.08

EV/EBITDA

-2.9 -16.3 -13.7 -18.6 -20.3 -14.6 -9.7 -8.6 -10.6 -2.6 -0.8

PEG

0.94 7.97 1.6 2.66 -1.19 1.92 -8.64 42.79 -0.92 0.1 -0.17 -0.06 -0.06

P/B

1.1 1.6 1.4 3.6 3.4 4.8 7.6 5.3 3.3 4.1 1.9 2.1 1.2

P/CF

-8.8 -9.0 -12.4 -23.7 -28.0 -38.5 -42.2 -27.5 -15.0 111.9 -4.5 -2.7 -2.1

ROE %

-13.74 -20.03 -12.11 -19.42 -17.28 -20.07 -28.89 -31.47 -27.01 -41.78 -15.84 -73.66 -75.47

ROA %

-12.93 -18.97 -11.59 -18.37 -16.34 -19.00 -25.71 -27.29 -23.33 -33.72 -13.63 -56.02 -57.60

ROCE %

-15.87 -20.83 -12.21 -19.36 -18.23 -20.77 -32.14 -28.50 -24.23 -35.92 -13.82 -59.07 -59.46

Current Ratio

17.0 19.0 23.4 27.7 28.9 28.6 9.8 15.2 15.2 7.6 31.2 4.3 4.2

DSO

- - - - - - - - - - 365.3 - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011400 400 300 300 200 200 100 100 0 0 -100 -100
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios MediciNova

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.06 -0.05 -0.06 - -0.01 -0.06 -0.06 - -0.07 -0.08 -0.07 - -0.07 -0.09 - - -0.08 -0.1 -0.06 - -0.05 -0.09 -0.11 - -0.16 -0.08 -0.12 -0.02 -0.11 -0.08 -0.09 -0.04 -0.08 -0.1 -0.11 -0.09 -0.06 -0.09 -0.09 -0.1 -0.1 -0.09 -0.1 0.15 -0.1 -0.14 -0.14 -0.14 -0.14 -0.14 -0.24 -0.22 -0.25 -0.31 -0.45

EBITDA per Share

- - -0.06 - - - -0.06 - -0.08 -0.08 -0.07 - -0.07 -0.09 - - -0.08 -0.1 -0.07 - -0.06 -0.1 -0.12 - -0.17 -0.08 -0.12 - -0.11 -0.08 -0.09 - -0.08 -0.1 -0.11 - -0.06 -0.09 -0.09 - -0.1 -0.09 -0.1 - -0.1 -0.13 -0.13 - -0.14 -0.14 -0.24 - -0.25 -0.24 -0.31

ROE %

-15.48 -11.42 -11.25 -9.83 -14.83 -18.71 -19.56 -14.47 -18.61 -17.75 -17.29 -9.14 -14.34 -15.39 -16.83 -15.24 -18.41 -16.40 -15.34 -14.63 -14.92 -21.01 -20.13 -20.07 -23.93 -24.38 -27.29 -28.89 -24.75 -15.04 -7.83 -0.03 -0.04 -0.03 -0.03 -0.03 -0.03 -0.04 -0.04 -0.04 13.39 4.60 -6.34 -15.85 -45.63 -52.82 -57.19 -73.66 -72.21 -72.80 -77.39 -75.47 -16.57 -19.92 -24.07

ROA %

-14.70 -10.85 -10.68 -9.34 -14.00 -17.60 -18.38 -13.64 -17.55 -16.80 -16.41 -8.67 -13.59 -14.59 -15.92 -14.41 -17.41 -15.51 -14.50 -13.83 -14.10 -19.88 -19.05 -19.00 -22.42 -22.29 -24.64 -25.71 -22.02 -13.38 -6.97 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.03 -0.03 11.53 3.96 -5.46 -13.64 -37.63 -42.21 -44.44 -56.01 -54.95 -55.44 -58.99 -57.60 -12.65 -15.20 -18.37

ROCE %

-18.33 -14.10 -13.85 -11.21 -16.54 -20.10 -20.38 -14.91 -19.08 -17.91 -17.40 -9.21 -14.44 -15.51 -17.00 -15.65 -19.19 -17.49 -16.75 -15.76 -25.38 -31.46 -30.53 -20.65 -30.46 -30.66 -33.27 -24.90 -33.13 -31.56 -33.58 -27.34 -32.21 -28.84 -26.51 -18.58 -29.24 -35.03 -37.75 -31.08 -39.90 -38.06 -39.34 -29.29 -45.17 -52.23 -56.64 -57.29 -73.92 -74.67 -75.13 -53.65 -16.63 -15.84 -21.18

Current Ratio

19.0 20.1 20.5 17.0 19.6 19.4 20.9 18.9 14.8 17.6 22.1 23.4 17.8 21.1 25.8 18.4 18.4 18.4 18.4 18.4 18.4 18.4 18.4 18.8 18.8 18.8 18.8 9.1 9.1 9.1 9.1 7.5 7.5 7.5 7.5 7.4 7.4 7.4 7.4 5.2 5.2 5.2 5.2 7.2 7.2 7.2 7.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2

DSO

- - - - - - - - - - - - - 45.6 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 91.4 168339.1 168339.1 84169.6 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - 45.6 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 91.4 168339.1 168339.1 84169.6 - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - 45.6 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 91.4 168339.1 168339.1 84169.6 - - - - - - - -
P/E
P/S
EPS
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011400 400 300 300 200 200 100 100 0 0 -100 -100
Download SVG
Download PNG
Download CSV

All numbers in USD currency